BCJ Capital Management »

Vertex Pharmaceuticals Incorporated shares owned by BCJ Capital Management

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by BCJ Capital Management from 13F filings

Historical chart of BCJ Capital Management investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by BCJ Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by BCJ Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $218k 556 391.64
2025-06-30 $239k 536 445.20
2025-03-31 $249k 513 484.82
2024-09-30 $204k 439 465.08
2024-06-30 $213k 455 468.72
2023-12-31 $5.1M 12k 406.89

More positions owned by BCJ Capital Management

Select Sector Spdr Tr Technology (XLK)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Core Msci Emkt (IEMG)
Select Sector Spdr Tr Financial (XLF)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Growth Etf (VUG)
Select Sector Spdr Tr Sbi Cons Discr (XLY)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr Core Total Usd (IUSB)
Select Sector Spdr Tr Sbi Healthcare (XLV)
Ishares Tr Core Msci Eafe (IEFA)
Select Sector Spdr Tr Communication (XLC)
Barclays Bank Ipath S&p 500 Sh (VXX)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Apple (AAPL)

View all positions for BCJ Capital Management

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
State Street Corporation
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Capital Research and Management Company - Division 3
Alliancebernstein
Loomis, Sayles and
Jennison Associates
Morgan Stanley
FMR
Ubs Global Asset Management Americas

View all funds holding Vertex Pharmaceuticals Incorporated